Invivyd, Inc.
Invivyd, Inc. (IVVD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IVVD · as of Jun 8, 2026
Key Statistics
Explore Invivyd, Inc. Data
ivvd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 57.1%
The IVVD analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $9.50, representing +831.37% upside from the current price of $1.02.
Competitors & Peers
ivvd competitorsIVVD
CCCC
CDXS
GNFT
IMDX
NTHIStock Performance
Full HistoryAbout Invivyd, Inc.
Invivyd, Inc. Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived …
what is invivyd, inc. · ivvd stock overview · invivyd, inc. company profile · who is invivyd, inc. ceo · ivvd NASDAQ · invivyd, inc. headquarters · invivyd, inc. business segments
About Stock Overview & Key Data
Invivyd, Inc. (IVVD) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 6, 2021. As of the latest trading session, IVVD stock price is $1.02, with a market capitalization of $135.4M. The stock has returned +4.83% over the past 12 months and -58.91% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Invivyd, Inc. stock is Buy, with an average 12-month price target of $9.50. In fiscal year 2025, Invivyd, Inc. reported revenue of $53.4M and net income of -$52.5M. For detailed data — including Invivyd, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Invivyd, Inc. (IVVD) stock price is $1.02. The stock is traded on NASDAQ under the ticker symbol IVVD. The 52-week range is $0.48 – $3.07.